Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Men had worse COVID-19 outcomes than women in New York City.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Post-finasteride syndrome's existence is uncertain; more research needed.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride doesn't affect bone density in male rats.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride helps induce ovulation in nonresponder PCOS women.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

PCOS is linked to changes in vaginal bacteria, with fewer good bacteria and more harmful ones.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Finasteride doesn't affect ovulation in normal women.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Excess maternal androgens can cause heart problems in offspring.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.